(Q44750215)

5 December 2017

Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria (English)

1 reference

5 December 2017

1 reference

Handa S

1

1 reference

PubMed ID

14754652

5 December 2017

Dogra S

series ordinal

2

1 reference

PubMed ID

14754652

5 December 2017

Kumar B

series ordinal

3

1 reference

5 December 2017

1 January 2004

1 reference

Journal of Dermatological Treatment

5 December 2017

1 reference

5 December 2017

15

1 reference

5 December 2017

1

1 reference

5 December 2017

55-57

1 reference

A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.

5 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F09546630310013450

Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630310013450

Twenty-four hours of activity of cetirizine and fexofenadine in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630310013450

Treatment of urticaria. An evidence-based evaluation of antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630310013450

Gas chromatographic method for the determination of cetirizine in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630310013450

Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630310013450

10.1080/09546630310013450

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference

PubMed ID

14754652